Superpower vs Neko Health: a yearly blood-test membership or a one-hour clinic scan?
By AppDuo Editorial Team · Updated
Quick verdict
Both services sell healthy adults an early look at their health, but in very different ways: Superpower is a yearly blood-testing membership, while Neko Health is a roughly one-hour clinic visit paid per scan. Each carries a documented criticism, and neither is available in Vietnam.
Superpower: listed at $199/year, with blood draws at 2,000+ US partner labs or at home (extra fee), results within 10 days, the Kin AI assistant and a care team you message in the app. Worth knowing: rival Function Health is suing, alleging the "100+ biomarkers" claim covers only about 55 directly measured values; there is no ruling. Its privacy policy also discloses sharing data with advertising platforms.
Neko Health: $499 per scan in the US, £299 (≈ $400) in the UK or 2,750 kr in Sweden, covering skin and body imaging, heart measurements, blood tests and a clinician consultation in the same visit. Worth knowing: experts quoted by UnHerd and The Week raise overdiagnosis concerns, Neko's own first-year figures have no control group, and clinics exist in only a few cities.
Head-to-head
Superpower leads on 2, Neko Health on 3, 5 even
| Feature | Superpower | Neko Health |
|---|---|---|
| Format and when results arrive[1],[9],[10] | Yearly membership: blood is drawn at a partner lab or at home, and results reach the app within 10 days (typically about a week, per the official site). | Paid per visit: a roughly one-hour clinic session, with results and a clinician consultation before you leave. |
| → Superpower suits ongoing blood tracking without a clinic trip; Neko suits people who want everything done in one visit with results explained face to face. | ||
| Price for individuals[1],[7],[9],[10],[11] | Membership: $199/year, billed once a year (US price, HSA/FSA eligible). At-home collection and add-on tests cost extra; one Trustpilot reviewer cites $150 for home collection. Pricing may differ in New York and New Jersey. | Neko Health Scan: $499 per scan in the US, £299 (≈ $400) in the UK, 2,750 kr in Sweden. The UK and Sweden pages say follow-up is included; the US page says certain follow-up care is included if the clinician recommends it. No monthly subscription. |
| → In the US, a year of Superpower lists for less than one Neko scan, but the two buy different things: Superpower is blood testing only, while Neko adds skin imaging, heart checks and a clinician visit. | ||
| What gets measured[1],[3],[5],[9],[10] | Annual blood testing advertised as 100+ biomarkers (Function Health alleges about 55 are directly measured), plus a biological age and 17 health scores. Gut, toxin and Galleri cancer-screening tests are sold separately. | Radiation-free skin and body imaging (with mole mapping), blood pressure and ECG, blood tests (50+ biomarkers per the US page), then a clinician consultation. |
| → If blood markers are the main interest, Superpower is the more focused option; skin and heart checks are only in Neko's visit. | ||
| Where it is available[1],[3],[9],[10],[11],[14],[17],[18] | US only as far as published: 2,000+ partner labs or home collection. No official information about service outside the US. | Sweden, the UK and the US, with clinics in a few cities (Stockholm, London, New York). The company has announced a Miami-area opening in December and a second New York clinic in January. |
| → Inside the US, Superpower is easier to reach because no clinic is needed nearby; in the UK or Sweden only Neko is an option. Neither serves Vietnam. | ||
| Who explains your results[1],[5],[9],[15] | The Kin AI assistant and a care team you message in the app, advertised as "24/7". Function Health's complaint alleges replies typically come within 24 hours on weekdays from dietitians or health coaches rather than physicians. | A face-to-face clinician consultation during the visit; per the app listing, Neko's specialists follow up in the app if anything is flagged. |
| → Anyone who wants a clinician to walk through the results gets that with Neko; with Superpower, who answers members is one of the points in dispute in the lawsuit. | ||
| Evidence of benefit[1],[5],[17],[18] | AppDuo's records hold no health-outcome figures published by Superpower; the current dispute is about its advertising rather than clinical benefit. | Neko publishes first-year Stockholm figures: 2,707 people scanned, 14% needing further attention or monitoring, 1% receiving "potentially life-saving" intervention. Neko itself says this is not a controlled study, and experts quoted by UnHerd say the data cannot show benefits or harms. |
| → Neither product's records include a controlled study showing benefit for healthy people, so treat both as a way to gather baseline data, not a replacement for recommended check-ups and screening. | ||
| Lawsuits and criticism[5],[6],[7],[17],[18] | Function Health sued Superpower on 26 January 2026 in the Central District of California over alleged false advertising (biomarker count, clinical team, testing locations). These are unproven allegations with no ruling; as of 10 March 2026 Superpower had not filed an answer. When checked on 11 November 2026, Trustpilot also withheld Superpower's rating, saying the company was "displaying Trustpilot content in a misleading way". | No lawsuit on record. The criticism comes from experts quoted by UnHerd and The Week: false positives, overdiagnosis and overtreatment, and follow-up work shifted to the NHS. Neko responded that the NHS offers "the most basic options"; no regulator action has been found. |
| → Superpower faces an undecided lawsuit and a withheld Trustpilot rating, both about how it presents itself, so they are worth reading before paying. Neko's criticism is expert opinion on scanning healthy people, with no lawsuit or regulator action found. | ||
| Health data[2],[12] | Says it does not sell personal information to other businesses for their advertising, but shares data with Meta, Google, Microsoft and LinkedIn for advertising, may sell de-identified data, and says HIPAA may not apply to it. Data sent to the AI is not used for model training. | Processed under UK GDPR (per the UK notice); care data is kept for eight years. Product and AI development use needs separate consent for each purpose, and your NHS GP is contacted only with consent. |
| → Anyone wary of health data reaching ad systems gets tighter terms from Neko, at the cost of a long retention period. | ||
| App and wearables[1],[3],[8],[15] | Web app and iPhone app (iOS 18 or later), English interface; connects Oura, Whoop and Apple Health and accepts past lab uploads. US App Store: 4.89/5 from 1,761 ratings. | iPhone app in English and Swedish that stores results, tracks changes between scans and pulls in Apple Health data; Neko says it is not a medical device. UK App Store: 4.8/5 from 12 ratings. |
| → Oura or Whoop wearers can see device data next to blood results in Superpower; Neko's App Store score rests on very few ratings. | ||
| Cancelling and refunds[1],[9] | Cancel anytime with no fees and keep access until the paid year ends; the pricing page states no refund policy. | The FAQ covers cancelling and rescheduling a booking; no published refund terms were found. |
| → Neither publishes refund terms, so check the conditions before paying for a year of Superpower or booking a Neko scan. | ||
Prices marked ≈ are converted to USD at the reference rate of Nov 11, 2026 (ExchangeRate-API) so they can be compared. What you pay follows the vendor's price and exchange rate.
Choose Superpower if…
- US residents who want yearly blood testing at a fixed cost without visiting a clinic
- Oura, Whoop or Apple Health users who want wearable data next to their lab results
- People untroubled by a pending lawsuit over its advertising and by data sharing with ad platforms
Choose Neko Health if…
- People living near a Neko clinic in Stockholm, London or New York
- People who want skin, mole and heart checks alongside blood tests, with a clinician in the same visit
- People who want stricter data terms, with AI and product-development use only by separate consent
Two different takes on preventive checks
Superpower is a membership from Superpower Health, Inc. in the US, launched publicly on 22 April 2025. You give blood at one of 2,000+ partner labs or at home, then see results on the web or iPhone app with a biological age, 17 health scores, the Kin AI assistant and a care team you message in the app. Gut, toxin and Galleri cancer-screening tests are extra purchases.
Neko Health is run by Neko Health AB of Sweden, founded in 2018 by Spotify co-founder Daniel Ek and Hjalmar Nilsonne. There is no annual plan: each time you book a roughly one-hour visit covering skin and body imaging, blood pressure and ECG, blood tests and a sit-down with a clinician to go through the results. The iPhone app stores results, compares scans over time and pulls in Apple Health data.
Price: comparing within the US market
Both sell to individuals and both list US prices. Superpower lists $199/year (HSA/FSA eligible, with pricing that may differ in New York and New Jersey); at its 2025 launch TechCrunch reported $499 for twice-yearly testing. Home collection costs extra, and one Trustpilot reviewer cites $150. Neko lists $499 per scan in the US, £299 (≈ $400) in the UK and 2,750 kr in Sweden; the UK and Sweden pages include follow-up, while the US page includes certain follow-up care when the clinician recommends it.
Superpower's lower figure does not buy the same thing: one is blood testing only, the other adds skin imaging, heart checks and clinician time. The Week quotes The Independent's wellbeing editor saying Neko's £300 (≈ $401) UK price "seems expensive for the average person", though more reasonable once items such as mole mapping are costed separately.
The lawsuit, overdiagnosis and the evidence
With Superpower, the issue is its marketing. According to law firm ArentFox Schiff, Function Health filed suit on 26 January 2026 (No. 2:26-cv-00810), alleging the membership includes about 55 directly measured values rather than "100+", that the "24/7" team is dietitians or health coaches, that the advertised "3,000+" testing locations exceed the roughly 2,250 centres of partner Quest, and that customer reviews were edited. These are a competitor's allegations, not established by a court; as of 10 March 2026 Superpower had not filed an answer, and the sources checked report nothing later.
With Neko, the question is whether healthy people should be scanned at all. In UnHerd, Swedish family doctor Minna Johansson says it is more likely a waste of money and time and that buyers may be harmed by overdiagnosis and overtreatment, calling the company's data "quite useless" for judging benefit. Neko states its first-year figures are not a controlled study and says the NHS offers only the most basic options. AppDuo's records hold no published health-outcome figures from Superpower to set against them.
If you live outside the US
Neither service is available in Vietnam. Superpower only mentions US testing locations and has an English-only interface, with no official information about other countries. Neko operates in Sweden, the UK and the US, with clinics in Stockholm, London and New York, and has announced a Miami-area opening and a second New York clinic. In the UK or Sweden, Neko is the only option of the two; in the US both are, and the choice comes down to distance to a clinic, budget and how you weigh the criticisms above.
Frequently asked questions
Which is cheaper, Superpower or Neko Health?
At US list prices, Superpower is $199/year and Neko is $499 per scan. Superpower covers blood testing only, with home collection and add-on tests extra; Neko also includes skin imaging, heart checks and a clinician. Neko is £299 (≈ $400) in the UK and 2,750 kr in Sweden.
Can people in Vietnam use either service?
No. Superpower only describes service in the US, and Neko's official site lists Sweden, the UK and the US only.
Has Function Health's lawsuit against Superpower been decided?
No. The complaint was filed on 26 January 2026 in federal court in California, alleging false advertising about the biomarker count, clinical team and testing locations. As of 10 March 2026 Superpower had not filed an answer, and the sources checked report no later developments.
Has Neko's scan been shown to help?
Not in a controlled study. Neko reports that 14% of people scanned in its first Stockholm year needed further attention and 1% received "potentially life-saving" intervention, but says itself this is not a controlled study. Experts quoted by UnHerd and The Week warn of false positives and overdiagnosis.
Can either replace seeing a doctor?
No. Superpower states it is not a substitute for medical advice, and Neko says its app is not a medical device and does not diagnose. Anyone with symptoms should go through regular medical care.
Sources
Numbers in the table refer to these sources, read on the dates shown.
- 1.Superpower official site · Vendor-provided · Nov 11, 2026
- 2.Superpower privacy policy · Vendor-provided · Nov 11, 2026
- 3.App Store listing · store · Nov 11, 2026
- 4.TechCrunch (2025-04-22) · press · Nov 11, 2026
- 5.ArentFox Schiff: Function Health sues Superpower · press · Nov 11, 2026
- 6.Endurance Sports Wire (2026-02-05) · press · Nov 11, 2026
- 7.Trustpilot: superpower.com · review-site · Nov 11, 2026
- 8.iTunes Lookup API: Superpower · store · Nov 11, 2026
- 9.Official site (UK) · Vendor-provided · Nov 11, 2026
- 10.Official site (US) · Vendor-provided · Nov 11, 2026
- 11.Official site (Sweden) · Vendor-provided · Nov 11, 2026
- 12.Privacy policy (UK) · Vendor-provided · Nov 11, 2026
- 13.Leadership, quality and patient safety · Vendor-provided · Nov 11, 2026
- 14.Press room · Vendor-provided · Nov 11, 2026
- 15.App Store listing (UK) · store · Nov 11, 2026
- 16.Wikipedia: Daniel Ek, Neko Health section · Community-reported · Nov 11, 2026
- 17.The Week US: full-body scans (2025-04-16) · press · Nov 11, 2026
- 18.UnHerd: the truth about private health scans (2025-01-20) · press · Nov 11, 2026
Comments
No comments yet. Be the first to share your experience.
Comments are readers’ opinions, not content from the AppDuo Editorial Team.

